Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CellCentric Makes Two Appointments

This article was originally published in Scrip

Executive Summary

CellCentric, a company developing anti-cancer compounds, has appointed Nigel Brooks director of translational science and Martin Page consultant. Brooks was previously involved in AstraZeneca Plc's clinical trials and he also led the AstraZeneca urology disease area team. He currently holds a senior leadership role at the Manchester Cancer Research Centre. Page brings experience in oncology R&D and held various senior management positions including European oncology therapeutic area head for Glaxo-Wellcome, and global head of oncology research for Johnson & Johnson Pharmaceuticals where he was vice president.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC064480

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel